NASDAQ: FBIO
Fortress Biotech Inc Stock Ownership - Who owns Fortress Biotech?

Insider buying vs selling

Have Fortress Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David JinChief Financial Officer2025-10-012,711$1.31
$3.55kBuy
David JinChief Financial Officer2025-04-015,000$1.22
$6.08kBuy

1 of 1

FBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FBIO insiders and whales buy or sell their stock.

FBIO Shareholders

What type of owners hold Fortress Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lindsay A. Md Rosenwald21.20%6,579,083$22.24MInsider
Elliott Associates LP6.69%2,076,381$7.02MInsider
Michael S. Weiss5.80%1,801,138$6.09MInsider
Elliott International LP5.33%1,654,898$5.59MInsider
David Jin4.02%1,248,604$4.22MInsider
Vanguard Group Inc3.06%950,327$3.21MInstitution
George Avgerinos2.11%655,170$2.21MInsider
Summit Financial LLC1.43%444,748$1.50MInstitution
Susquehanna International Group LLP1.15%356,178$1.20MInstitution
Shikiar Asset Management Inc0.90%278,469$941.23kInstitution

1 of 3

FBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FBIO14.16%48.94%Net Buying
GNLX19.57%7.44%Net SellingNet Selling
CBUS19.61%80.39%Net Buying
ONCY2.72%1.99%Net BuyingNet Buying
SEER42.91%57.09%Net SellingNet Selling

Fortress Biotech Stock Ownership FAQ

Who owns Fortress Biotech?

Fortress Biotech (NASDAQ: FBIO) is owned by 14.16% institutional shareholders, 48.94% Fortress Biotech insiders, and 36.90% retail investors. Lindsay A. Md Rosenwald is the largest individual Fortress Biotech shareholder, owning 6.58M shares representing 21.20% of the company. Lindsay A. Md Rosenwald's Fortress Biotech shares are currently valued at $22.11M.

If you're new to stock investing, here's how to buy Fortress Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.